CC vs HON: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: CC is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CC and HON share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CC and HON exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

The Chemours Company is a US-listed specialty chemicals producer spun out of DuPont in 2015. It reports through three segments: Thermal & Specialized Solutions (refrigerants and thermal management, led by the Opteon low-global-warming-potential product line), Titanium Technologies (TiO2 white pigment used in paints, plastics, and paper), and Advanced Performance Materials (high-end fluoropolymers and advanced materials). Full-year 2025 net sales were roughly $5.8 billion, and the company operates globally across industrial, construction, automotive, and electronics end markets.

Full CC guide

Honeywell International is a diversified industrial technology conglomerate that makes a broad range of products and software across aerospace, building automation, energy and sustainability, and industrial automation. Its Aerospace segment supplies engines, avionics, and systems for commercial and defense aircraft and earns recurring aftermarket revenue servicing them. Its Building Automation business sells controls, sensors, fire and security systems for commercial buildings. Energy and Sustainability Solutions includes specialty chemicals, materials, and process technologies, while Industrial Automation covers warehouse and process control, sensing, and the productivity (barcode scanning) business. Honeywell makes money from a mix of equipment sales, long-cycle projects, recurring aftermarket service, and growing software offerings. The company has been reshaping its portfolio, spinning off and acquiring businesses to focus on aerospace, automation, and energy transition. Founded in its modern form through a 1999 merger and headquartered in Charlotte, North Carolina, Honeywell is a large, broadly held industrial blue chip.

Full HON guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CC drivers: Opteon refrigerant growth; TiO2 pigment cyclical recovery.
• HON drivers: Aerospace aftermarket strength; Portfolio reshaping and software.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: PFAS environmental litigation and remediation are the defining risk: Chemours faces thousands of personal injury claims in the AFFF multi-district litigation with bellwether trials that could produce unpredictable damages, on top of the $450 million EPA and DOJ settlement already reached in 2026. For HON, as a diversified industrial, Honeywell is exposed to the broad economic cycle, with several segments sensitive to construction, manufacturing capex, and energy markets.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CC if you believe its drivers more; HON if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CC and HON guides.

CC. Chemours trades at a low equity valuation relative to its ~$5.8 billion revenue base, reflecting cyclical earnings and PFAS liability overhang rather than a high-growth multiple. Q1 2026 showed revenue up modestly year over year but a net loss, with 2026 guidance calling for 3 to 5 percent sales growth. EV/EBITDA has run in the low-to-mid teens, so much of the enterprise value sits in debt and litigation obligations.

HON. Honeywell trades at a valuation typical of a high-quality diversified industrial, reflecting solid margins, strong cash generation, a durable aerospace aftermarket, and a reliable dividend, balanced against modest organic growth and cyclical exposure. The market values its quality and stability while watching whether portfolio reshaping and software can lift growth above the broad industrial average.

Headline figures (approximate, JULY 2026): CC shows revenue (fy2025) ~$5.8B, q1 2026 revenue ~$1.38B, q1 2026 net loss ~$29M, 2026 adj. ebitda guide ~$800-900M; HON shows revenue (ttm) ~$39 billion, operating margin ~20%, net income (ttm) ~$5.5 billion, p/e (ttm) ~22x.

CC and HON are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CC and HON exposure against your real portfolio. It is not an investment adviser.